PHOTO GALLERY
Please view below moments captures during the forum. Please contact [email protected] if you would wish to use any of the pictures for commercial purposes or you need a version without Sachs Associates watermark. |
Supported by:
Pharma Licensing Groups in 2018 include:
Investors & Analysts Attending:
203 Investment Partners LLC
A C Binder Corp. Abingworth LLP Aegis Capital Corp. Aisling Capital Alpine Equity Advisors Arcus Ventures Bioqube Ventures BioSeed Capital BioSense Global LLC Biotech Alliances International, Inc. Bradley Woods & Co. Brookline Capital Markets C-Bridge Capital Canaccord Genuity, Inc. CBT Advisors Crown Point Group CTI Life Sciences Deca Ventures Double U Fund/ Kareg Enso Ventures ESC Advisors Excellentia Global Partners Click Here to View All |
SACHS BIOCAPITAL USA FORUM
FOR PHARMA-BIOTECH PARTNERING & INVESTMENT OPPORTUNITIES
NEW YORK ACADEMY OF SCIENCES, USA
POST FORUM SITE
Sachs Associates Switzerland AG
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: [email protected]
© COPYRIGHT 2023. ALL RIGHTS RESERVED.